Advancing Cancer Awareness, Prevention, and Early Detection
About the Initiative
- Mission
- Why this campaign matters
- Program goals
- Community impact
- Frequently Asked Questions
Find an Event
- Interactive listing
- City
- State
- Disease focus
- Month
Homepage
- Hero banner
- Campaign overview
- Call-to-action
- Featured upcoming activations
- Disease awareness highlights
- Partner logos
Q1 ─ Community Conversations
Q2 ─ Awareness
The Prostate Project
Breast Health Blueprint
Q3 ─ Prevention
Q4 ─ Awareness
The Prostate Project
Breast Health Blueprint
Community Activations
This will likely become one of the most frequently visited sections.
Each activation should have its own page with:
- Event description
- Date
- Time
- Address
- Registration
- Map
- Partner organizations
- What to expect
- FAQs
Health Information Sources
The health information contained in this material is based on guidance and research from the American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), U.S. Preventive Services Task Force (USPSTF), and other nationally recognized cancer organizations.
This information is intended for educational purposes only and should not replace advice from your healthcare provider. Talk with your physician or healthcare team about the screening schedule that is right for you based on your age, family history, and personal risk factors.
Key Statistics Used
- Black men have the highest incidence of prostate cancer in the United States.
- Black men are approximately 1.7 times more likely to be diagnosed with prostate cancer than White men.
- Black men are about twice as likely to die from prostate cancer.
- Prostate cancer often has no symptoms in its early stages.
- A PSA (Prostate-Specific Antigen) blood test is commonly the first step in prostate cancer screening. A digital rectal exam (DRE) is not required simply to obtain a PSA level, though it may be recommended in some situations after discussion with a healthcare provider.
Primary Sources
American Cancer Society
Cancer Facts & Figures for African American/Black People
- Black men have the highest prostate cancer incidence.
- Mortality is approximately twice that of White men.
- Early detection improves treatment outcomes.
Centers for Disease Control and Prevention (CDC)
Prostate Cancer
- Explains risk factors, symptoms, PSA testing, and screening discussions.
- Notes that Black men are at higher risk and should discuss screening earlier with their healthcare provider.
National Cancer Institute
Provides evidence-based information on:
- PSA testing
- Benefits and limitations of screening
- Treatment outcomes
- Risk factors
U.S. Preventive Services Task Force (USPSTF)
Current recommendation:
- Men ages 55–69 should make individualized decisions regarding PSA screening after discussing benefits and harms with their healthcare provider.
- Men at increased risk (including many Black men and those with a strong family history) may benefit from earlier discussions with their clinician.
Key Statistics Used
- Breast cancer is the most commonly diagnosed cancer among women (excluding some skin cancers).
- Black women are slightly less likely than White women to develop breast cancer overall.
- Black women are approximately 40% more likely to die from breast cancer.
- Black women are more likely to develop triple-negative breast cancer, an aggressive subtype.
- Mammograms can detect breast cancer before it can be felt, improving treatment options and survival.
Primary Sources
American Cancer Society
Reports that:
- Black women experience significantly higher breast cancer mortality.
- Screening mammography saves lives.
- Understanding family history and risk factors is important.
Centers for Disease Control and Prevention
Provides information on:
- Mammograms
- Symptoms
- Breast self-awareness
- Risk factors
- Screening recommendations
National Cancer Institute
Provides evidence regarding:
- Triple-negative breast cancer
- Survival disparities
- Risk factors
- Screening
U.S. Preventive Services Task Force
Current recommendation:
- Biennial screening mammography for women ages 40–74 at average risk.
- Women with higher risk should discuss earlier or additional screening with their healthcare provider.